Long-term re-intervention after USgHIFU and prediction of NPVR in different ages of patients with uterine fibroids

References

• Stewart EA, Cookson CL, Gandolfo RA, et al. Epidemiology of uterine fibroids: a systematic review. BJOG. 2017;124(10):1501–1512. doi:10.1111/1471-0528.14640.
   PubMed Web of Science ®Google Scholar
• Foth D, Röhl FW, Friedrich C, et al. Symptoms of uterine myomas: data of an epidemiological study in Germany. Arch Gynecol Obstet. 2017;295(2):415–426. doi:10.1007/s00404-016-4239-y.
   PubMed Web of Science ®Google Scholar
• Scheurig-Muenkler C, Koesters C, Powerski MJ, et al. Clinical long-term outcome after uterine artery embolization: sustained symptom control and improvement of quality of life. J Vasc Interv Radiol. 2013;24(6):765–771. doi:10.1016/j.jvir.2013.02.018.
   PubMed Web of Science ®Google Scholar
• Moss JG, Cooper KG, Khaund A, et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5-year results. BJOG. 2011;118(8):936–944. doi:10.1111/j.1471-0528.2011.02952.x.
   PubMed Web of Science ®Google Scholar
• Chen J, Li Y, Wang Z, et al. Evaluation of high-intensity focused ultrasound ablation for uterine fibroids: an IDEAL prospective exploration study. BJOG. 2018;125(3):354–364. doi:10.1111/1471-0528.14689.
   PubMed Web of Science ®Google Scholar
• Jacoby VL, Kohi MP, Poder L, et al. PROMISe trial: a pilot, randomized, placebo-controlled trial of magnetic resonance guided focused ultrasound for uterine fibroids. Fertil Steril. 2016;105(3):773–780. doi:10.1016/j.fertnstert.2015.11.014.
   PubMed Web of Science ®Google Scholar
• Ikink ME, Nijenhuis RJ, Verkooijen HM, et al. Volumetric MR-guided high-intensity focused ultrasound versus uterine artery embolisation for treatment of symptomatic uterine fibroids: comparison of symptom improvement and reintervention rates. Eur Radiol. 2014;24(10):2649–2657. doi:10.1007/s00330-014-3295-6.
   PubMed Web of Science ®Google Scholar
• Stewart EA, Rabinovici J, Tempany CM, et al. Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertil Steril. 2006;85(1):22–29. doi:10.1016/j.fertnstert.2005.04.072.
   PubMed Web of Science ®Google Scholar
• Chen J, Chen W, Zhang L, et al. Safety of ultrasound-guided ultrasound ablation for uterine fibroids and adenomyosis: a review of 9988 cases. Ultrason Sonochem. 2015;27:671–676. doi:10.1016/j.ultsonch.2015.05.031.
   PubMed Web of Science ®Google Scholar
• Radosa MP, Owsianowski Z, Mothes A, et al. Long-term risk of fibroid recurrence after laparoscopic myomectomy. Eur J Obstet Gynecol Reprod Biol. 2014;180:35–39. doi:10.1016/j.ejogrb.2014.05.029.
   PubMed Web of Science ®Google Scholar
• Li W, Jiang Z, Deng X, et al. Long-term follow-up outcome and reintervention analysis of ultrasound-guided high intensity focused ultrasound treatment for uterine fibroids. Int J Hyperthermia. 2020;37(1):1046–1051. doi:10.1080/02656736.2020.1807617.
   PubMed Web of Science ®Google Scholar
• Gomez E, Nguyen MT, Fursevich D, et al. MRI-based pictorial review of the FIGO classification system for uterine fibroids. Abdom Radiol . 2021;46(5):2146–2155. doi:10.1007/s00261-020-02882-z.
   PubMed Web of Science ®Google Scholar
• Zhao WP, Chen JY, Zhang L, et al. Feasibility of ultrasound-guided high intensity focused ultrasound ablating uterine fibroids with hyperintense on T2-weighted MR imaging. Eur J Radiol. 2013;82(1):e43-9–e49. doi:10.1016/j.ejrad.2012.08.020.
   PubMed Web of Science ®Google Scholar
• Duc NM, Keserci B. Emerging clinical applications of high-intensity focused ultrasound. Diagn Interv Radiol. 2019;25(5):398–409. doi:10.5152/dir.2019.18556.
   PubMed Web of Science ®Google Scholar
• Li W, Yang Z, Gao B, et al. Comparison of ultrasound-guided high-intensity focused ultrasound ablation and hysteroscopic myomectomy for submucosal fibroids: a retrospective study. Int J Hyperthermia. 2021;38(1):1609–1616. doi:10.1080/02656736.2021.1995053.
   PubMed Web of Science ®Google Scholar
• Sandberg EM, Tummers F, Cohen SL, et al. Reintervention risk and quality of life outcomes after uterine-sparing interventions for fibroids: a systematic review and meta-analysis. Fertil Steril. 2018;109(4):698–707.e1. doi:10.1016/j.fertnstert.2017.11.033.
   PubMed Web of Science ®Google Scholar
• Fauconnier A, Chapron C, Babaki-Fard K, et al. Recurrence of leiomyomata after myomectomy. Hum Reprod Update. 2000;6(6):595–602. doi:10.1093/humupd/6.6.595.
   PubMed Web of Science ®Google Scholar
• Hanafi M. Predictors of leiomyoma recurrence after myomectomy. Obstet Gynecol. 2005;105(4):877–881. doi:10.1097/01.AOG.0000156298.74317.62.
   PubMed Web of Science ®Google Scholar
• Englund K, Blanck A, Gustavsson I, et al. Sex steroid receptors in human myometrium and fibroids: changes during the menstrual cycle and gonadotropin-releasing hormone treatment. J Clin Endocrinol Metabolism. 1998;83(11):4092–4096. doi:10.1210/jc.83.11.4092.
   PubMed Web of Science ®Google Scholar
• Stewart EA, Gostout B, Rabinovici J, et al. Sustained relief of leiomyoma symptoms by using focused ultrasound surgery. Obstet Gynecol. 2007;110(2 Pt 1):279–287. doi:10.1097/01.AOG.0000275283.39475.f6.
   PubMed Web of Science ®Google Scholar
• Keserci B, Duc NM. The role of T1 perfusion-based classification in magnetic resonance-guided high-intensity focused ultrasound ablation of uterine fibroids. Eur Radiol. 2017;27(12):5299–5308. doi:10.1007/s00330-017-4885-x.
   PubMed Web of Science ®Google Scholar
• Lénárd ZM, McDannold NJ, Fennessy FM, et al. Uterine leiomyomas: MR imaging-guided focused ultrasound surgery–imaging predictors of success. Radiology. 2008;249(1):187–194. doi:10.1148/radiol.2491071600.
   PubMed Web of Science ®Google Scholar
• Park MJ, Kim YS, Rhim H, et al. Safety and therapeutic efficacy of complete or near-complete ablation of symptomatic uterine fibroid tumors by MR imaging-guided high-intensity focused US therapy. J Vasc Interv Radiol. 2014;25(2):231–239. doi:10.1016/j.jvir.2013.11.011.
   PubMed Web of Science ®Google Scholar
• Mindjuk I, Trumm CG, Herzog P, et al. MRI predictors of clinical success in MR-guided focused ultrasound (MRgFUS) treatments of uterine fibroids: results from a single centre. Eur Radiol. 2015;25(5):1317–1328. doi:10.1007/s00330-014-3538-6.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang ZB, Xu YH. Efficacy, efficiency, and safety of magnetic resonance-guided high-intensity focused ultrasound for ablation of uterine fibroids: comparison with ultrasound-guided method. Korean J Radiol. 2018;19(4):724–732. doi:10.3348/kjr.2018.19.4.724.
   PubMed Web of Science ®Google Scholar
• Gong X, Zhang X, Liu D, et al. Physician experience in technical success of achieving NPVR ≥ 80% of high-intensity focused ultrasound ablation for uterine fibroids: a multicenter study. Front Med Technol. 2021;3:790956. doi:10.3389/fmedt.2021.790956.
   PubMedGoogle Scholar
• Gong X, Liu D, Yang MJ, et al. Tolerance and efficacy of HIFU ablation for uterine fibroids NPVR ≥ 90%: a nested case-control study. Int J Hyperthermia. 2022;39(1):946–951. doi:10.1080/02656736.2022.2093414.
   PubMed Web of Science ®Google Scholar
• Jiang L, Yu JW, Yang MJ, et al. Ultrasound-guided HIFU for uterine fibroids of hyperintense on T2-weighted MR imaging with or without GnRH-analogue-pretreated: a propensity score matched cohort study. Front Surg. 2022;9:975839. doi:10.3389/fsurg.2022.975839.
   PubMed Web of Science ®Google Scholar
• Yang Z, Zhang Y, Zhang R, et al. A case-control study of high-intensity focused ultrasound combined with sonographically guided intratumoral ethanol injection in the treatment of uterine fibroids. J Ultrasound Med. 2014;33(4):657–665. doi:10.7863/ultra.33.4.657.
   PubMed Web of Science ®Google Scholar
• Panganamamula UR, Harmanli OH, Isik-Akbay EF, et al. Is prior uterine surgery a risk factor for adenomyosis? Obstet Gynecol. 2004;104(5 Pt 1):1034–1038. doi:10.1097/01.AOG.0000143264.59822.73.
   PubMed Web of Science ®Google Scholar
• Yu O, Schulze-Rath R, Grafton J, et al. Adenomyosis incidence, prevalence and treatment: United States population-based study 2006-2015. Am J Obstet Gynecol. 2020;223(1):94.e1–e10. doi:10.1016/j.ajog.2020.01.016.
   PubMed Web of Science ®Google Scholar